A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)

NCT02634346 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

403

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: ALK3831
DRUG: Olanzapine
DRUG: Placebo

Sponsor

Alkermes, Inc.